These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 16191423
1. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis. Ji Z, Huang C, Liang C, Chen B, Chen S, Sun W. Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423 [Abstract] [Full Text] [Related]
2. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril. Hu P, Qin YH, Pei J, Lei FY, Hu B, Lu L. Exp Mol Pathol; 2010 Aug; 89(1):51-7. PubMed ID: 20493835 [Abstract] [Full Text] [Related]
3. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ. J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [Abstract] [Full Text] [Related]
4. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats. Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N. Regul Pept; 2005 Dec 15; 132(1-3):59-66. PubMed ID: 16229907 [Abstract] [Full Text] [Related]
5. [Mechanism of the effect of Tongluo Recipe against glomerular sclerosis in rats]. Wu XL, Sun WS, Zhang WG, Wang Z. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul 15; 28(7):1198-201. PubMed ID: 18676262 [Abstract] [Full Text] [Related]
6. [The effects of blocking intrarenal renin-angiotensin system on the expression of transforming growth factor-beta1 mRNA and extracellular matrix components]. Zhou C, Li J, Wang H. Zhonghua Nei Ke Za Zhi; 1999 Jan 15; 38(1):44-6. PubMed ID: 11798627 [Abstract] [Full Text] [Related]
7. [The effect of losartan on glomerular sclerosis in rats with diabetic nephropathy]. Xu JY, Tao LJ, Wang L, Ning WB, Liu JS. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 15; 33(9):836-40. PubMed ID: 18812664 [Abstract] [Full Text] [Related]
8. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH. Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983 [Abstract] [Full Text] [Related]
9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A. Ann Acad Med Stetin; 1999 May 20; Suppl 52():1-93. PubMed ID: 10589103 [Abstract] [Full Text] [Related]
10. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 May 20; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
11. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R. J Pharmacol Exp Ther; 2006 Jan 20; 316(1):8-16. PubMed ID: 16166267 [Abstract] [Full Text] [Related]
12. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS. Exp Clin Endocrinol Diabetes; 2007 Oct 20; 115(9):571-6. PubMed ID: 17943690 [Abstract] [Full Text] [Related]
13. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways. Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ. Clin Exp Pharmacol Physiol; 2009 Mar 20; 36(3):287-96. PubMed ID: 19018797 [Abstract] [Full Text] [Related]
14. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients. Renke M, Tylicki L, Rutkowski P, Wojnarowski K, Lysiak-Szydlowska W, Rutkowski B. Scand J Urol Nephrol; 2005 Mar 20; 39(6):511-7. PubMed ID: 16303729 [Abstract] [Full Text] [Related]
15. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. Zhou TB, Qin YH, Lei FY, Su LN, Zhao YJ, Huang WF. Exp Mol Pathol; 2011 Jun 20; 90(3):287-94. PubMed ID: 21385580 [Abstract] [Full Text] [Related]
16. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M, Rodrigue ME, Agharazii M, Larivière R. Am J Hypertens; 2006 Dec 20; 19(12):1286-92. PubMed ID: 17161776 [Abstract] [Full Text] [Related]
17. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. Zhu S, Liu Y, Wang L, Meng QH. Nephrol Dial Transplant; 2008 Sep 20; 23(9):2841-6. PubMed ID: 18390891 [Abstract] [Full Text] [Related]
18. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy. Kim HJ, Ryu JH, Han SW, Park IK, Paik SS, Park MH, Paik DJ, Chung HS, Kim SW, Lee JU. Nephron Physiol; 2004 Sep 20; 97(4):p58-65. PubMed ID: 15331931 [Abstract] [Full Text] [Related]
19. Renal protective effects of blocking the intrarenal renin-angiotensin system. Li J, Zhou C, Yu L, Wang H. Hypertens Res; 1999 Sep 20; 22(3):223-8. PubMed ID: 10515446 [Abstract] [Full Text] [Related]
20. [Expression of type I transforming growth factor beta receptor in renal cortex in streptozotocin-induced diabetic rats and the regulation of benazepril]. Wu Y, Lin S. Zhonghua Nei Ke Za Zhi; 1999 Jan 20; 38(1):9-13. PubMed ID: 11798618 [Abstract] [Full Text] [Related] Page: [Next] [New Search]